| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $70.93M | $80.96M | $55.29M | $34.46M | $17.65M |
| R&D | – | – | – | – | – |
| SG&A | – | – | – | $1.86M | $1.83M |
| Operating Income | – | – | – | -$33.42M | -$16.85M |
| Interest Expense | – | – | $44.48M | $23.45M | $8.62M |
| Tax Expense | – | – | – | – | – |
| Net Income | -$3.17M | $47.67M | $107.84M | -$74.48M | $19.06M |
| EPS (basic) | 1.6600 | 1.9300 | 2.2600 | -3.2200 | 1.4700 |
| EPS (diluted) | 1.6600 | 1.9300 | 2.2600 | -3.2200 | 1.4700 |
| Shares (diluted) | $32.13M | $32.35M | $25.70M | $23.13M | $15.49M |